BiotechTube

Anticoagulant

Pre-clinicalUNKNOWN
0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anticoagulant-induced Bleeding

Conditions

Anticoagulant-induced Bleeding, Intracranial Hemorrhages

Trial Timeline

Aug 9, 2023 → Jan 31, 2024

NCT ID
NCT06168838

About Anticoagulant

Anticoagulant is a pre-clinical stage product being developed by AstraZeneca for Anticoagulant-induced Bleeding. The current trial status is unknown. This product is registered under clinical trial identifier NCT06168838. Target conditions include Anticoagulant-induced Bleeding, Intracranial Hemorrhages.

Hype Score Breakdown

Clinical
3
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06168838Pre-clinicalUNKNOWN